Filing Details

Accession Number:
0001171843-15-003968
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-07-22 16:58:59
Reporting Period:
2015-07-20
Filing Date:
2015-07-22
Accepted Time:
2015-07-22 16:58:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1365216 Sucampo Pharmaceuticals Inc. SCMP Pharmaceutical Preparations (2834) 133929237
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1311726 J Thomas Knapp 4520 East West Highway, 3Rd Floor
Bethesda MD 20814
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2015-07-20 45,000 $14.82 45,000 No 4 M Direct
Class A Common Stock Disposition 2015-07-20 45,000 $23.43 0 No 4 S Direct
Class A Common Stock Acquisiton 2015-07-20 6,810 $6.75 6,810 No 4 M Direct
Class A Common Stock Disposition 2015-07-20 6,810 $23.43 0 No 4 S Direct
Class A Common Stock Acquisiton 2015-07-20 12,718 $6.75 12,718 No 4 M Direct
Class A Common Stock Disposition 2015-07-20 12,718 $23.43 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Employee Stock Option (right to buy) Disposition 2015-07-20 45,000 $0.00 45,000 $14.82
Class A Common Stock Employee Stock Option (right to buy) Disposition 2015-07-20 6,810 $0.00 6,810 $6.75
Class A Common Stock Employee Stock Option (right to buy) Disposition 2015-07-20 12,718 $0.00 12,718 $6.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
235,650 2015-03-31 2015-08-31 No 4 M Direct
228,840 2015-03-31 2015-08-31 No 4 M Direct
216,122 2015-03-31 2015-08-31 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.25 to $24.03, inclusive. The reporting person undertakes to provide Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.